Amlodipine camsylate/Losartan Potassium/Chlorthalidone

樟脑磺酸氨氯地平/氯沙坦钾/氯噻酮

Report date: 2026/02/02 17:44:52

Base Information

Drug NameAmlodipine camsylate/Losartan Potassium/Chlorthalidone
Drug Alias NameAmosartan Plus
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/06/29
Country/TerritorySouth Korea
CombinationsYes Losartan PotassiumAmlodipine CamsylateChlorthalidone
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A